LifeStance Health Group Inc

Aktienanalyse zu LifeStance Health Group Inc (LFST)

$12.520

+0.203 (+1.62%)Zum Schluss

Loading chart…
Hoch
12.530
Eröffnung
12.200
Volumengewichteter Durchschnittskurs
12.40
Volumen
3.44M
Marktkap.
1.87B
Tief
12.161
Umsatz
42.73M
EV/EBITDA, TTM
23.72

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

KI-Analyse of LifeStance Health Group Inc (LFST)

Kaufen

LifeStance Health Group Inc is a good buy right now, trading at $12.42 with a strong year-to-date change of +78.45% and a one-year change of +143.05%. The RSI is at 66.39, indicating strong momentum, while the forward P/E ratio of 52.63 suggests growth potential. The main risk is the insider selling, with the CTO selling 42,067 shares, which could indicate profit-taking, but he still retains a significant stake worth $2.6 million.

Bewertungskennzahlen

Das aktuelle erwartete KGV von LifeStance Health Group Inc (LFST) beträgt 52.63, verglichen mit dem 5-Jahres-Durchschnitt von 8.43.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
8.43
Aktuelles P/E
52.63
Überbewertet
104.26
Unterbewertet
-87.40

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
35.26
Aktuelles EV/EBITDA
23.72
Überbewertet
50.80
Unterbewertet
19.71

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
2.30
Aktuelles P/S
2.39
Überbewertet
3.16
Unterbewertet
1.44

Alphio-AI-Kursszenarien für LFST

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%LFST

$8.88

Szenariopreis

B

Basis

Basis · 50%LFST

$8.02

Szenariopreis

B

Bärisch

Bärisch · 25%LFST

$6.83

Szenariopreis

Whales, die LFST halten

I

Integral Health Asset Management, LLC

+ HältLFST

-8.58%

3-Monats-Rendite

T

TPG Capital, L.P.

+ HältLFST

-9.33%

3-Monats-Rendite

Event-Zeitleiste

2026-09-09 (ET)

09:00:00

Barclays Acts as Sole Book Running Manager for Offering

07:30:00

LifeStance Health Group to Offer 22.25M Shares of Common Stock

2026-08-10 (ET)

12:30:00

LifeStance Stock Rises 13.2% to $12.27

2026-08-06 (ET)

07:01:00

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

07:01:00

Sees Q3 Adjusted EBITDA of $49M-$59M

News

LFST FAQ – beantwortet von Alphio AI

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

LifeStance Health Group Inc is a good buy right now, trading at $12.42 with a strong year-to-date change of +78.45% and a one-year change of +143.05%. The RSI is at 66.39, indicating strong momentum, while the forward P/E ratio of 52.63 suggests growth potential. The main risk is the insider selling, with the CTO selling 42,067 shares, which could indicate profit-taking, but he still retains a significant stake worth $2.6 million.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln